NCT05135689

Brief Summary

This study is part of a national vision to fight against serophobia and support society towards more ethical and benevolent practices vis-à-vis aging and specific populations. The main objective of this study is to assess over the past five years the prevalence of people living with the Human Immunodeficiency Virus (HIV) aged 60 years and over and its evolution within the Paris Region medico-social structures

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
260

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 22, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 15, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 26, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

January 12, 2023

Status Verified

January 1, 2023

Enrollment Period

2.1 years

First QC Date

November 15, 2021

Last Update Submit

January 11, 2023

Conditions

Keywords

HIV-positiveSerophobia

Outcome Measures

Primary Outcomes (2)

  • The number of past situations for the last 5 years before the implementation of the study - of elderly people living with HIV in Retirement Home (EHPAD), home nursing care departments (SSIAD) and extended care units (USLD) in Île-de-France.

    2 years

  • The number of current situations for the last 5 years before the implementation of the study - of elderly people living with HIV in Retirement Home (EHPAD), home nursing care departments (SSIAD) and extended care units (USLD) in Île-de-France.

    2 years

Secondary Outcomes (10)

  • Assessment of the degree of patient dependence according "Index of Independence in Activities of Daily Living" KATZ scale

    2 years

  • Assessment of patient's level of dependence through an appreciation of instrumental activities of daily living according Lawton scale

    2 years

  • Assessment of depression according MINI Geriatric depression scale (Mini-GDS)

    2 years

  • Screening for undernutrition using Mini Nutritional Assessment (MNA)

    2 years

  • Assessment of quality of life according WHOQOL-HIV-BREF SCORE

    2 years

  • +5 more secondary outcomes

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

HIV-positive patients in Paris region medico-social sector, their informal caregivers and health professionals in the medico-social sector.

You may qualify if:

  • For patients:
  • HIV-positive, regardless of strain or age of infection,
  • Orally expressing his non-opposition to his participation in the study and documented in the medical file by investigator,
  • Follow-up, placed and / or treated in one of the centers concerned by the scope of the study in Paris Region.
  • Since informal caregivers can be included in the study by being linked to a previously included patient, the patient must agree to share the status with informal caregiver, or have previously shared their status with informal caregiver.
  • Patients with legal protection may participate only if:
  • They clearly agree that their legal representative should be consulted on participation in the study,
  • They accept that this person is aware of their HIV status ,
  • After having been consulted, this person (legally responsible) does not object to the participation of the person for whom he is responsible.
  • For informal caregiver:
  • Person having a caring activity, before and during the study (such as the spouse, a child, a parent, neighbor, support person, etc.), for his close patient participating in the study,
  • Authorized by the patient to be offered the study; the patient's agreement to approach the informal caregiver will have been sought beforehand in order to prevent the lack of medical confidentiality,
  • Person expressing orally his non-opposition to his participation in the study and documented in the medical file of the patient to whom he is helping,
  • Person capable of understanding the questionnaires and assessments of the study and able to answer them without the assistance of a third party.
  • For health professionals :
  • +2 more criteria

You may not qualify if:

  • For patients:
  • Patient expressing his opposition to his participation in the study,
  • Patient who - according to the investigator - is unable to understand the study or answer the study questionnaires,
  • For informal caregivers:
  • Person not having a helping activity or exercising his role of helping for remuneration, or exercising his role of helping a loved one not included in the study,
  • Person who exercises his role of helping in the context of a voluntary or associative activity,
  • Person expressing orally his opposition to his participation in the study and documented in the medical file of the patient to whom he is helping,
  • Person unable to understand the questionnaires and evaluations of the study and who is not able to answer them without the help of a third party,
  • Person having the status of legal representative of the patient as part of a legal protection measure (guardianship and others).
  • For health professionals :
  • Health professional working in the non-Francilians health or medico-social sector,
  • Health professional opposing participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geriatric Department, Broca hospital

Paris, IIe-de-France, 75013, France

RECRUITING

MeSH Terms

Conditions

HIV Seropositivity

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Olivier Hanon, MD PhD

    Geriatric Department, Broca hospital,

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 15, 2021

First Posted

November 26, 2021

Study Start

September 22, 2021

Primary Completion

November 1, 2023

Study Completion

October 1, 2024

Last Updated

January 12, 2023

Record last verified: 2023-01

Locations